ASX soars on firming rate cuts
The benchmark ASX 200 jumped 51.80 points or 0.60 per cent to 8,756.40, with the market lifting after 11.30am on the CPI data from the Australian Bureau of Statistics.
The broader All Ordinaries also traded higher up 48.70 points or 0.54 per cent to 9,015.40.
Australia's dollar slid on the news down 0.05 per cent to US 65.09 cents.
Six of the 11 sectors finished in the green. The ASX 200 jumped on the back of quarterly inflation data. Photo: Gaye Gerard / NewsWire Credit: News Corp Australia
Shares related to a rate cut jumped on the news.
Gains were led by the major banks with bourse heavyweight CBA up 1.55 per cent to $176.99, NAB gained 0.71 per cent to $38.47, Westpac jumped 1.60 per cent to $33.72 and ANZ closed 1.25 per cent higher to $30.70.
Woolworths Group added 1.58 per cent to $31.44, Coles jumped 1.72 per cent to $20.65 and Endeavour Group is up 1.23 per cent to $4.12.
Stockland shares jumped 2.21 per cent to $5.55, Charter Hall Group gained 1.76 per cent to $20.21 and Mirvac Group gained 2.73 per cent to $2.26.
Betashare chief economist David Bassanese said near enough was good enough for a rate cut as trimmed mean inflation fell to 2.7 per cent for the 12 months until June.
'Underlying inflation is inching closer to the middle of the RBA's 2 to 3 per cent target band and so justifies a further easing in what – in the RBA's own words – a still 'modestly restrictive' level of interest rates,' he said. Six of the 11 sectors gained on Wednesday. Photo: Gaye Gerard / NewsWire Credit: News Corp Australia
Josh Gilbert, market analyst for eToro, described it as hard for the RBA to hold rates.
'After the surprise pause in July, today's data means an August rate cut is all but nailed on,' he said.
'Markets are now pricing a 93 per cent chance of a cut, and it's easy to see why. Cost-of-living pressures are easing, and the risk is now skewed towards holding rates too high for too long.'
In company news, Rio Tinto half-yearly earnings fell to a five-year low on the back of weaker iron ore prices throughout the previous six months.
The major iron ore exporter told the market its underlying profits came in at $US4.8bn for the first six months until June 30, which is down from $US5.75bn ($8.83bn) last year
Interim dividends fall to $US1.48 a share versus $1.77 a year ago
Embattled casino operator Star Entertainment used its quarterly update to announce the sale of its Queen's Wharf precinct in Brisbane was 'unlikely' to go through by Thursday's deadline.
But it also pointed to an improving cash position with Star having $234m in cash and $269m in cash equivalents, as of June 30, up from $44m at the end of March.
Shares in Star Entertainment Group slumped 4.35 per cent to $0.11 following the announcement.
Pointsbet shares rallied a further 4.2 per cent to $1.25 after rival wagering business Betr upped its takeover offer.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
an hour ago
- News.com.au
ASX Tech July Winners: A strong month as AI fever takes hold; iSynergy rockets 1,000pc
Wall Street tech rockets on earnings and stimulus ASX tech shines as inflation cools and rate hopes rise IS3 explodes 1000% on AI cloud ambitions What happened globally in July? After months of tweet-storms and tariff theatrics, July finally served up something investors hadn't tasted in a while ... clarity. Both the Nasdaq and S&P 500 hit fresh all-time highs during the month, riding a wave of solid earnings and the sense that maybe Washington was done setting things on fire. US growth stocks outpaced value 2-to-1, and nearly 80% of S&P 500 companies beat earnings expectations, according to figures from JPMorgan. Trump's new trade deals - first with Vietnam, then Japan and the EU - dialled down the tension. Tariffs are still chunky (15-20%), but investors would rather deal with known pain than flinch at every tweet. Then there was the real sugar hit: Trump's 'One Big Beautiful Bill Act' finally got the green light in July, promising another round of fiscal stimulus. On the quarterly reporting front, the Magnificent Seven's earnings surged 21.6% year-on-year while the rest of the market huffed along at just 4%. Alphabet and Apple lit the match, and Nvidia rode the rocket to new highs. But Tesla dropped more than 8% after Elon muttered something about 'difficult times' ahead. ASX tech stocks had strong month Then we pan back to the local stage, where the ASX 200 clocked a tidy 2.36% gain for July, its fourth straight winning month. With inflation cooling to 2.1% for the June quarter, punters started betting the RBA might soon loosen the screws. Rate cut hopes always put a bit more spring in the market's step. Among the 11 sectors, healthcare stole the spotlight. After months stuck in the recovery ward, health ripped back with a near 9% gain, making it July's best performer. That finally gave investors a reason to stop writing 'under review' next to their CSL notes. Tech also stacked on a 5% gain for the month, thanks to a mix of AI optimism and real earnings momentum. But some analysts reckon this market is still on a short rope. Profits have been falling for three years straight but valuations are still sitting up around 19x forward earnings. And the only thing keeping investors from bolting to cash are growth sectors like tech and biotech. ASX tech winners in July Code Name Price Month % Change Market Cap IS3 I Synergy Group Ltd 0.011 1000% 18,769,299 CT1 Constellation Tech 0.002 100% 2,949,467 NVQ Noviqtech Limited 0.042 83% 10,564,535 NVU Nanoveu Limited 0.069 68% 63,433,796 DRO Droneshield Limited 3.750 64% 3,279,820,703 AI1 Adisyn Ltd 0.070 59% 50,688,792 NOV Novatti Group Ltd 0.030 58% 16,799,952 ATV Activeportgroupltd 0.014 56% 9,617,679 OEC Orbital Corp Limited 0.145 53% 23,893,059 LIS Lisenergylimited 0.160 52% 102,432,037 WBT Weebit Nano Ltd 2.420 49% 504,472,157 BEO Beonic Ltd 0.300 43% 21,258,302 OLL Openlearning 0.017 42% 8,205,469 AXE Archer Materials 0.290 35% 73,905,634 FL1 First Lithium Ltd 0.100 33% 7,965,360 HYD Hydrix Limited 0.017 31% 4,637,070 ICE Icetana Limited 0.072 29% 38,291,466 AT1 Atomo Diagnostics 0.018 29% 14,177,803 SMN Structural Monitor. 0.530 28% 81,834,675 SP3 Specturltd 0.015 25% 4,753,502 ZMM Zimi Ltd 0.010 25% 4,900,438 360 Life360 Inc. 40.160 25% 6,827,390,399 8CO 8Common Limited 0.021 24% 4,705,993 KYP Kinatico Ltd 0.240 23% 103,702,076 1CG One Click Group Ltd 0.011 22% 13,005,148 FLX Felix Group 0.220 22% 45,190,339 X2M X2M Connect Limited 0.019 21% 8,266,080 QOR Qoria Limited 0.600 21% 800,177,642 HSN Hansen Technologies 6.010 21% 1,226,308,647 DTI DTI Group Ltd 0.006 20% 5,382,617 ID8 Identitii Limited 0.006 20% 4,668,081 ODA Orcoda Limited 0.078 20% 14,626,109 ROC Rocketboots 0.097 20% 16,617,395 AMO Ambertech Limited 0.185 19% 17,649,885 FCL Fineos Corp Hold PLC 2.760 18% 934,351,756 NVX Novonix Limited 0.450 18% 286,775,115 PHX Pharmx Technologies 0.110 18% 65,835,747 JCS Jcurve Solutions 0.046 18% 15,195,798 XYZ Block Inc 120.940 18% 5,466,116,351 HCL Highcom Ltd 0.365 18% 37,479,175 EPX EPX Limited 0.027 17% 17,811,282 DCC Digitalx Limited 0.088 17% 129,806,213 JAN Janison Edu Group 0.170 17% 44,181,003 CYB Aucyber Limited 0.080 16% 16,699,810 RUL Rpmglobal Hldgs Ltd 3.370 16% 743,859,780 CAT Catapult Grp Int Ltd 6.630 13% 1,880,880,300 EOS Electro Optic Sys. 3.210 13% 619,376,238 RKN Reckon Limited 0.535 13% 60,612,735 CML Connected Minerals 0.140 12% 5,790,150 SEN Senetas Corporation 0.019 12% 31,464,363 TAL Talius Group Limited 0.068 11% 19,498,919 BLG Bluglass Limited 0.010 11% 25,764,258 DUB Dubber Corp Ltd 0.020 11% 52,500,599 EXT Excite Technology 0.010 11% 20,726,419 PPS Praemium Limited 0.705 10% 336,789,198 RCL Readcloud 0.110 10% 16,898,174 IFM Infomedia Ltd 1.300 10% 491,945,597 XF1 Xref Limited 0.170 10% 37,415,260 ERD Eroad Limited 1.420 10% 266,207,194 WTC Wisetech Global Ltd 119.380 9% 39,947,292,069 RKT Rocketdna Ltd. 0.012 9% 10,986,279 RWL Rubicon Water 0.190 9% 45,732,069 TYR Tyro Payments 0.955 9% 504,871,747 CCR Credit Clear 0.255 9% 108,285,404 IKE Ikegps Group Ltd 0.910 8% 167,050,840 NXL Nuix Limited 2.370 8% 783,837,994 DDR Dicker Data Limited 8.720 8% 1,575,634,092 SPX Spenda Limited 0.008 7% 34,614,116 ATA Atturralimited 0.855 7% 324,036,918 GTI Gratifii 0.099 6% 37,599,343 FCT Firstwave Cloud Tech 0.017 6% 29,129,818 HTG Harvest Tech Grp Ltd 0.017 6% 15,453,311 EVS Envirosuite Ltd 0.088 6% 127,774,253 CPU Computershare Ltd 42.150 6% 24,379,015,001 BRN Brainchip Ltd 0.205 5% 415,277,056 NOR Norwood Systems Ltd. 0.021 5% 10,834,480 OAK Oakridge 0.067 5% 1,808,860 WHK Whitehawk Limited 0.012 5% 8,525,483 ASB Austal Limited 6.560 4% 2,762,941,089 MP1 Megaport Limited 15.060 4% 2,423,776,460 CDA Codan Limited 20.950 4% 3,803,909,140 CF1 Complii Fintech Ltd 0.025 4% 14,289,450 BCC Beam Communications 0.130 4% 11,234,850 CXZ Connexion Mobility 0.026 4% 20,832,933 UBN Ltd 0.870 4% 68,417,589 SNS Sensen Networks Ltd 0.030 3% 23,791,124 CGO CPT Global Limited 0.062 3% 2,597,637 XRG Xreality Group Ltd 0.032 3% 23,793,521 KNO Knosys Limited 0.036 3% 7,780,993 VR1 Vection Technologies 0.038 3% 67,200,032 EIQ Echoiq Ltd 0.225 2% 145,167,235 SLX Silex Systems 4.250 1% 1,011,949,327 XRO Xero Ltd 180.990 1% 29,932,420,128 iSynergy Group (ASX:IS3) IS3 shares soared 1000% in July after it inked a non-binding MoU with Nasdaq-listed Treasure Global (TGL) to explore a $600,000 deal for AI chips and cloud infrastructure in Malaysia. The plan is to buy advanced GPUs over 12 months and potentially co-develop regional AI data centres. While the MoU isn't binding and no money's changed hands yet, it marks IS3's first serious step into AI infrastructure, aligning with its broader goal to scale up digital capabilities and regional reach. The share price surge caught the ASX's attention, prompting a speeding ticket. IS3 responded by confirming it had been in early talks, which had now been formalised in the MoU, but stressed the discussions were 'substantially incomplete' and didn't justify the share price spike. Still, the market clearly saw something it liked in IS3's AI ambitions, and ran with it. NoviqTech (ASX:NVQ) NoviqTech fired the starter's pistol on its quantum push in July. The company launched a new subsidiary called Quantum Intelligence to bring quantum computing, AI and blockchain to mainstream enterprise. It's kicking off with a September beta of two subscription-based tools: QI Provenance for tamper-proof digital trust and QI AI for blockchain-backed decision-making. Later this year, NVQ rolls out the full Quantum Intelligence Platform, powered by NVIDIA CUDA-Q, promising up to 10x performance for heavy workloads like logistics, finance and cryptography. To back it, NVQ has locked in a $1.25m placement at 3.6c a share and secured long-term global rights to the QI software from Singapore-based Morphotech. The licence is non-exclusive and royalty-free until NVQ hits profitability. Nanoveu (ASX:NVU) In July, Nanoveu took a major leap from simulation to silicon, kicking off synthesis of its ultra-efficient 16nm ECS-DoT chip in partnership with Cairo's Centre of Nanoelectronics. The chip is designed for smart edge devices, from wearables to autonomous systems. Alongside it, Nanoveu launched a modular AIoT kit to fast-track prototyping across sectors like healthcare and logistics, and opened early access for developers. To fuel the rollout, the company raised $2 million from high-net-worth backers at 5.5c a share, giving it the runway to finish chip production and scale commercial testing. With phase 2 drone trials now underway, Nanoveu is putting ECS-DoT through its paces in real-world environments. The aim is to validate its energy efficiency after earlier simulations showed a 33% boost in drone flight endurance. DroneShield (ASX:DRO) DroneShield had a bumper July, with major announcements sending its share price flying. First up, it secured a $5 million slice of a $16.9m Australian Defence Force contract under LAND156, supplying handheld gear to knock out rogue drones. Then came the big swing. DroneShield committed $13m to triple its Sydney production space and expand R&D, as it ramps up to meet booming global demand. The upgrade pushes total annual manufacturing capacity to $2.4 billion by end-2026. This was backed by fresh wins including a $61.6m European deal and an $11.7m R&D contract with a Five Eyes defence department, its fourth with the same customer. DroneShield is scaling fast and gearing up for serious global defence action. Adisyn (ASX:AI1) Adisyn has installed and commissioned its new Atomic Layer Deposition (ALD) system at its Israeli research site, marking a big step forward in its graphene R&D push. The upgraded Beneq TFS 200 machine gives Adisyn the firepower to deposit ultra-thin graphene layers with greater speed, precision and control. This is crucial for developing low-temperature graphene solutions aimed at next-gen semiconductor interconnects. The system will run in tandem with a second unit already operating at Tel Aviv University, allowing Adisyn to accelerate validation across different substrates and conditions. The dual ALD setup sets the stage for Adisyn to fast-track its graphene roadmap and move closer to real-world chip integration. ASX tech losers in July Code Name Price Month % Change Market Cap 1TT Thrive Tribe Tech 0.010 -50% 1,015,864 VIG Victor Group Hldgs 0.049 -36% 31,959,107 AR9 Archtis Limited 0.155 -33% 52,584,833 XPN Xpon Technologies 0.007 -22% 2,899,773 OPL Opyl Limited 0.023 -21% 5,652,671 AD8 Audinate Group Ltd 6.150 -18% 518,027,839 GTK Gentrack Group Ltd 9.750 -15% 1,050,288,486 DXN DXN Limited 0.061 -15% 18,220,922 AVA AVA Risk Group Ltd 0.085 -15% 24,690,122 AJX Alexium Int Group 0.006 -14% 9,518,572 VNL Vinyl Group Ltd 0.099 -14% 133,309,975 COS Cosol Limited 0.583 -13% 106,008,474 FND Findi Limited 3.710 -13% 229,282,530 EOL Energy One Limited 13.200 -12% 413,561,056 TZL TZ Limited 0.048 -11% 13,469,477 SKO Serko 2.620 -11% 326,452,393 SPZ Smart Parking Ltd 0.800 -10% 328,122,329 ESK Etherstack PLC 0.450 -8% 59,675,401 3DP Pointerra Limited 0.046 -8% 37,033,533 PRO Prophecy Internation 0.400 -7% 29,499,574 SPA Spacetalk Ltd 0.150 -6% 10,966,902 PFM Platformo Ltd 0.076 -5% 7,213,031 YOJ Yojee Limited 0.380 -4% 132,577,872 5GN 5G Networks Limited 0.135 -4% 40,208,638 DWG Dataworks Group 0.084 -3% 8,586,820 EML EML Payments Ltd 1.125 -3% 430,449,460 BVS Bravura Solution Ltd 2.150 -3% 963,961,104 SOR Strategic Elements 0.031 -3% 14,690,871 ASV Assetvisonco 0.037 -3% 27,541,378 SMP Smartpay Holdings 1.015 -2% 245,572,616 ACE Acusensus Limited 0.930 -2% 130,400,752 DUG DUG Tech 1.340 -1% 180,441,185 ELS Elsight Ltd 1.750 -1% 379,811,826 RDY Readytech Holdings 2.270 -1% 280,490,523 DTL Data#3 Limited 7.540 -1% 1,168,008,831 IRE IRESS Limited 7.940 -1% 1,483,108,424 VGL Vista Group Int Ltd 3.230 -1% 771,435,051 OCL Objective Corp 19.050 -1% 1,821,184,686
News.com.au
an hour ago
- News.com.au
ASX Health July Winners: Sector finally catches a bid to rebound 9pc for month
The S&P ASX 200 Health Care index rose 9.05% in July with rotation into the sector gaining momentum Lumos soared 170% in July after six-year exclusive deal valued at up to US$317 million with PHASE Scientific for distribution of FebriDX in US subject to CLIA waiver Clever Culture Systems rose 81.3% in July on news global pharmaceutical giant Novo Nordisk purchased one of its flagship APAS Independence instruments for evaluation The healthcare sector rose 9.05% in July to be the best of the 11 ASX sectors. A turn up for the books to be sure. While remaining the worst performing sector YTD – up just 1.81% – the S&P ASX Health Care index was in recovery mode in July. The sector was buoyed by a roughly 13% rise in its biggest name blood products giant CSL (ASX:CSL), which drives much of the index. Morgans' healthcare analyst Iain Wilkie said there appeared to be a strong sector rotation on the ASX in July. "During July there certainly was a rotation out of usual strong sectors like financials and more into healthcare and the miners," he told Stockhead. "Healthcare has been beaten down for quite a long while now and is starting to look attractive. "I don't think there was anything specific in terms of a catalyst to drive the rotation." Looking ahead, Wilkie noted the sector may face continued pressure with US President Donald Trump again threatening tariffs " at a very, very, high rate, like 200%" on imported pharmaceuticals. "Trump has again thrown his weight around but until it actually hits we'll see," Wilkie said. He said US tariffs shouldn't affect companies like CSL, which is one of the world's largest manufacturers of plasma products. "Although the US collects over 60% of the world's plasma, it lacks sufficient domestic capacity to process it into finished therapies," he said. "As a result, imported plasma products are critical to meeting national demand. "Introducing tariffs on these products would likely be counterproductive as they wouldn't foster viable domestic alternatives and could drive up costs, potentially limiting patient access and causing harm." How ASX biotechs performed in July CODE COMPANY PRICE 1 MONTH RETURN % MARKET CAP PAB Patrys Limited $ 0.002 181.8% 6.9 LDX Lumos Diagnostics $ 0.073 170.4% 55.4 NSB Neuroscientific $ 0.235 170.1% 79.8 NXS Next Science Limited $ 0.140 109.0% 41.7 NOX Noxopharm Limited $ 0.110 103.7% 30.7 CMB Cambium Bio Limited $ 0.425 102.4% 8.2 DVL Dorsavi Ltd $ 0.028 86.7% 27.3 ICR Intelicare Holdings $ 0.013 85.7% 6.3 CC5 Clever Culture $ 0.029 81.3% 56.9 EMD Emyria Limited $ 0.049 75.0% 28.1 CU6 Clarity Pharma $ 4.370 74.8% 1,471.5 HMD Heramed Limited $ 0.012 71.4% 10.5 MX1 Micro-X Limited $ 0.083 69.4% 54.0 TTX Tetratherix Limited $ 5.020 66.2% 131.7 CAN Cann Group Ltd $ 0.016 60.0% 9.8 NYR Nyrada Inc. $ 0.370 54.2% 77.8 VBS Vectus Biosystems $ 0.06 50.0% 3.2 CSX Cleanspace Holdings $ 0.760 46.2% 59.5 MSB Mesoblast Limited $ 2.380 43.8% 3,046.3 AVE Avecho Biotech Ltd $ 0.005 42.9% 15.9 HIQ Hitiq Limited $ 0.020 42.9% 9.9 AYA Artryalimited $ 1.025 42.4% 116.7 ANR Anatara Ls Ltd $ 0.007 40.0% 1.5 ATH Alterity Therap Ltd $ 0.014 40.0% 128.9 CBL Control Bionics $ 0.040 37.9% 12.1 EYE Nova EYE Medical Ltd $ 0.150 36.4% 41.2 IBX Imagion Biosys Ltd $ 0.015 36.4% 3.0 IPD Impedimed Limited $ 0.047 34.3% 93.4 RCE Recce Pharmaceutical $ 0.388 33.6% 108.4 NTI Neurotech Intl $ 0.020 33.3% 21.0 VFX Visionflex Group Ltd $ 0.00 33.3% 6.7 AT1 Atomo Diagnostics $ 0.018 28.6% 14.2 AHC Austco Healthcare $ 0.370 27.6% 137.0 TRP Tissue Repair $ 0.240 26.3% 14.5 SOM SomnoMed Limited $ 0.815 25.4% 171.8 1AD Adalta Limited $ 0.003 25.0% 2.8 ADR Adherium Ltd $ 0.005 25.0% 9.0 BIT Biotron Limited $ 0.003 25.0% 3.3 CUV Clinuvel Pharmaceut. $ 12.970 25.0% 617.5 FRE Firebrickpharma $ 0.077 24.2% 17.5 CMP Compumedics Limited $ 0.315 23.5% 66.3 NEU Neuren Pharmaceut. $ 17.290 22.5% 2,150.6 ILA Island Pharma $ 0.170 21.4% 40.8 ATX Amplia Therapeutics $ 0.240 20.0% 111.9 DOC Doctor Care Anywhere $ 0.125 19.0% 47.7 EBR EBR Systems $ 1.410 18.0% 514.6 LTP Ltr Pharma Limited $ 0.340 17.2% 60.6 PAR Paradigm Bio. $ 0.355 16.4% 136.1 LGP Little Green Pharma $ 0.115 16.2% 35.1 M7T Mach7 Tech Limited $ 0.380 15.2% 89.3 ALC Alcidion Group Ltd $ 0.115 15.0% 154.4 NC6 Nanollose Limited $ 0.077 14.9% 24.1 CYC Cyclopharm Limited $ 1.040 14.3% 113.4 SPL Starpharma Holdings $ 0.100 13.6% 43.9 MVF Monash IVF Group Ltd $ 0.800 13.5% 309.8 SNT Syntara Limited $ 0.060 13.2% 97.6 CSL CSL Limited $ 270.900 13.1% 128,514.7 PME Pro Medicus Limited $ 321.890 12.9% 33,058.3 CVB Curvebeam Ai Limited $ 0.080 12.7% 33.2 IMM Immutep Ltd $ 0.270 12.5% 385.3 MVP Medical Developments $ 0.610 11.9% 64.8 TRJ Trajan Group Holding $ 0.800 11.9% 121.9 GLH Global Health Ltd $ 0.076 11.8% 4.5 VIT Vitura Health Ltd $ 0.07 11.3% 47.0 PIQ Proteomics Int Lab $ 0.360 10.8% 57.3 IRX Inhalerx Limited $ 0.042 10.5% 9.0 IDT IDT Australia Ltd $ 0.098 10.1% 40.7 NUZ Neurizon Therapeutic $ 0.170 9.7% 81.2 PGC Paragon Care Limited $ 0.400 9.6% 653.8 RHY Rhythm Biosciences $ 0.059 9.3% 17.4 1AI Algorae Pharma $ 0.006 9.1% 10.1 CTQ Careteq Limited $ 0.012 9.1% 2.8 AHX Apiam Animal Health $ 0.565 8.7% 103.0 ARX Aroa Biosurgery $ 0.630 8.6% 224.3 OCC Orthocell Limited $ 1.275 8.5% 309.7 MAP Microbalifesciences $ 0.092 8.2% 47.4 PSQ Pacific Smiles Grp $ 1.670 8.1% 269.9 PNV Polynovo Limited $ 1.290 7.9% 858.4 RMD ResMed Inc. $ 42.450 7.9% 61,930.3 PTX Prescient Ltd $ 0.047 6.8% 38.7 REG Regis Healthcare Ltd $ 8.370 6.8% 2,545.6 TYP Tryptamine Ltd $ 0.03 6.7% 44.6 SDI SDI Limited $ 0.883 6.3% 104.6 COH Cochlear Limited $ 318.520 6.0% 20,541.2 RHC Ramsay Health Care $ 38.770 5.7% 8,808.5 IDX Integral Diagnostics $ 2.670 5.1% 1,001.8 IMC Immuron Limited $ 0.064 4.9% 16.9 OCA Oceania Healthc Ltd $ 0.660 4.8% 461.5 EBO Ebos Group Ltd $ 37.250 4.7% 7,552.6 RAD Radiopharm $ 0.023 4.5% 54.4 ACW Actinogen Medical $ 0.024 4.3% 76.3 IIQ Inoviq Ltd $ 0.385 4.1% 43.5 AGH Althea Group $ 0.026 4.0% 21.4 IME Imexhs Limited $ 0.300 3.4% 15.8 CYP Cynata Therapeutics $ 0.155 3.3% 37.3 SHL Sonic Healthcare $ 27.610 3.1% 13,532.2 FPH Fisher & Paykel H. $ 34.090 1.4% 19,481.0 CTE Cryosite Limited $ 0.750 0.7% 36.6 VLS Vita Life Sciences.. $ 2.26 0.4% 124.4 ACR Acrux Limited $ 0.016 0.0% 7.0 BP8 Bph Global Ltd $ 0.002 0.0% 2.1 EMV Emvision Medical $ 1.740 0.0% 150.1 EOF Ecofibre Limited $ 0.020 0.0% 7.6 EPN Epsilon Healthcare $ 0.024 0.0% 7.2 NAN Nanosonics Limited $ 4.050 0.0% 1,196.3 OSX Osteopore Limited $ 0.011 0.0% 2.6 TD1 Tali Digital Limited $ 0.001 0.0% 4.2 TRI Trivarx Ltd $ 0.008 0.0% 5.0 TRU Truscreen $ 0.016 0.0% 12.3 ACL Au Clinical Labs $ 2.760 -0.7% 536.1 CGS Cogstate Ltd $ 1.730 -0.9% 292.9 MYX Mayne Pharma Ltd $ 4.950 -1.0% 405.4 ANN Ansell Limited $ 29.950 -1.1% 4,410.5 AFP Aft Pharmaceuticals $ 2.400 -1.2% 259.6 RGT Argent Biopharma Ltd $ 0.080 -1.2% 4.7 RAC Race Oncology Ltd $ 1.160 -1.3% 198.9 SNZ Summerset Grp Hldgs $ 10.300 -1.3% 2,513.8 HLS Healius $ 0.770 -1.9% 548.2 ALA Arovella Therapeutic $ 0.098 -2.0% 117.7 BMT Beamtree Holdings $ 0.245 -2.0% 72.6 ONE Oneview Healthcare $ 0.245 -2.0% 185.7 4DX 4Dmedical Limited $ 0.235 -2.1% 136.2 COV Cleo Diagnostics $ 0.380 -2.6% 48.8 RHT Resonance Health $ 0.038 -2.6% 17.5 AVH Avita Medical $ 1.670 -2.6% 217.6 SIG Sigma Health Ltd $ 2.890 -3.3% 32,726.4 PYC PYC Therapeutics $ 1.240 -4.2% 729.1 IXC Invex Ther $ 0.085 -4.5% 6.9 OIL Optiscan Imaging $ 0.105 -4.5% 87.7 ZLD Zelira Therapeutics $ 0.41 -6.8% 4.9 MDR Medadvisor Limited $ 0.075 -7.4% 43.8 BDX Bcaldiagnostics $ 0.058 -7.9% 20.5 GSS Genetic Signatures $ 0.330 -9.6% 76.1 CDX Cardiex Limited $ 0.036 -10.0% 18.7 PER Percheron $ 0.009 -10.0% 10.9 AGN Argenica $ 0.680 -10.5% 86.1 OSL Oncosil Medical $ 1.070 -10.8% 20.2 ECS ECS Botanics Holding $ 0.008 -11.1% 11.0 PEB Pacific Edge $ 0.085 -11.5% 75.9 IVX Invion Ltd $ 0.096 -12.7% 8.2 EZZ EZZ Life Science $ 2.030 -13.2% 99.1 TLX Telix Pharmaceutical $ 21.050 -13.8% 6,991.3 AVR Anteris Technologies $ 5.130 -16.4% 179.8 DXB Dimerix Ltd $ 0.470 -18.3% 285.1 SHG Singular Health $ 0.300 -18.9% 93.5 IMR Imricor Med Sys $ 1.225 -19.4% 324.2 MEM Memphasys Ltd $ 0.004 -20.0% 7.9 PCK Painchek Ltd $ 0.035 -22.2% 66.3 CHM Chimeric Therapeutic $ 0.003 -25.0% 11.4 VHL Vitasora Health Ltd $ 0.03 -28.2% 46.4 UCM Uscom Limited $ 0.01 -31.3% 2.9 UBI Universal Biosensors $ 0.02 -31.4% 7.2 IMU Imugene Limited $ 0.270 -38.9% 77.2 BOT Botanix Pharma Ltd $ 0.150 -53.1% 289.3 Patrys (ASX:PAB) rose ~182% in July after announcing a solid June quarter including a board restructure, $300,000 capital raise and actively pursuing partnering and licensing opportunities for both of its oncological cell therapy deoxymab assets. In July Patrys also announced a fully underwritten, pro-rata non-renounceable entitlement offer of three fully paid ordinary shares for every four shares held at an issue price of $0.001 per Share, together with on free-attaching new share for every four shares applied for and issued, to raise up to ~$1.78m. Lumos Diagnostics (ASX:LDX) rose more than 170% in July after l anding a landmark six-year distributor deal worth hundreds of millions of dollars to sell its rapid point-of-care diagnostic FebriDx in the US market. The FebriDx product is a simple test able to differentiate between bacterial and non-bacterial acute respiratory infections. The lucrative US licensing deal with Hong-Kong based PHASE Scientific could see Lumos net up to to US$317m (~A$487m), and has been described as one of the largest distribution deals of its type to be done by an ASX-listed point-of-care diagnostics company. Adelaide-based Clever Culture Systems (ASX:CC5), rose 81.3% in July after announcing global pharmaceutical giant Novo Nordisk had purchased one of its flagship APAS Independence instruments for evaluation. The machine will be delivered to Novo's central team in Denmark, where it will undergo a full-scale evaluation to assess its suitability for deployment across Novo's global manufacturing network. The APAS Independence uses AI technology to automate one of the most time-consuming parts of microbiology, analysing agar plates for contamination. Radiopharmaceutical group Clarity Pharmaceuticals (ASX:CU6) was up 74.8% in July after completing a large $203m institutional placement at a 15% premium to the company's 15-day average price, to fund their clinical program. Executive chairman Dr Alan Taylor told Stockhead the 'fast, well executed and sizeable' placement was to a small group of local institutional investors "close to the company". 'I have never done a deal that fast,' Taylor said. 'A week ago, I would have said we were not doing a capital raising, but there was a lot of interest from a very concentrated group .' At Stockhead, we tell it like it is. While Lumos Diagnostics and Clever Culture Systems are Stockhead advertisers, the companies did not sponsor this article. The views, information, or opinions expressed in the interview in this article are solely those of the interviewee and do not represent the views of Stockhead.
The Age
3 hours ago
- The Age
ASX set to jump as Wall Street rallies; Retailer surges as Trump backs Sydney Sweeney ad
US stocks are rallying and recovering much of their sharp losses from last week, when worries about how President Donald Trump's tariffs may be punishing the economy sent a shudder through Wall Street. The S&P 500 jumped 1.3 per cent in afternoon trading to claw back more than two thirds of Friday's drop. The Dow Jones was up 493 points, or 1.1 per cent, in mid-afternoon trade, and the Nasdaq composite was 1.8 per cent higher. The Australian sharemarket is set to bounce higher, with futures pointing to a rise of 83 points, or 0.9 per cent, at the open. The ASX closed flat on Monday. Idexx Laboratories helped lead the way on Wall Street and soared 26 per cent after the seller of veterinary instruments and other health care products reported a stronger profit for the spring than analysts expected. It also raised its forecast for profit over the full year. Tyson Foods likewise delivered a bigger-than-expected profit for the latest quarter, and the company behind the Jimmy Dean and Hillshire Farms brands climbed 3.2 per cent. They helped offset a 3.5 per cent drop for Berkshire Hathaway after Warren Buffett's company reported a drop in profit for its second quarter from a year earlier. The weakening was due in part to the falling value of its investment in Kraft Heinz. The pressure is on US companies to deliver bigger profits after their stock prices shot to record after record recently. The jump in stock prices from a low point in April raised criticism that the broad market had become too expensive. Loading Stocks just sank to their worst week since May not so much on that criticism but on worries that Trump's tariffs may be hitting the US economy following a longer wait than some economists had expected. Job growth slowed sharply last month, and the unemployment rate worsened to 4.2 per cent. Trump reacted to the disappointing jobs numbers by firing the person in charge of compiling them. He also continued his criticism of the Federal Reserve, which could lower interest rates in order to shoot adrenaline into the economy. The Fed has instead been keeping rates on pause this year, in part because lower rates can send inflation higher, and Trump's tariffs may be set to increase prices for US households.
